| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Neuraxis, Inc.'s insiders have accumulated 2,533 shares worth roughly $12K on balance. In the past 30 days, 3 insiders bought and 0 sold. The tilt toward buying has held up recently.
The largest recent buyer is Carrico Brian Allen (Chief Executive Officer), now holding an estimated $1.1M in NRXS. Open-market purchases by a top executive tend to carry more weight than sales, which are often driven by diversification or scheduled 10b5-1 plans.
Classified under Biotechnology (Health Care sector), NRXS's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 1.21M | $5.96M | - | |
| CEO | 227.6K | $1.10M | +268 | |
| Other | 199.7K | $966.4K | +328 | |
| Dir | 80.1K | $502.8K | - | |
| Dir | 72.4K | $454.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 28, 2023 | Hannasch Brian72 | 10% Owner | Sell | 76 | $2.61 | $198.36 | - | +31.0% | -4.7% |